Reye-like syndrome following treatment with the pantothenic acid antagonist, calcium hopantenate

J Neurol Neurosurg Psychiatry. 1988 Apr;51(4):582-5. doi: 10.1136/jnnp.51.4.582.

Abstract

Three senile patients developed fatal acute encephalopathy while receiving calcium hopantenate. The clinical, biochemical, and pathological picture was similar to Reye's syndrome. Calcium hopantenate is a pantothenic acid antagonist. The serum levels of calcium hopantenate were high in coma, and that of pantothenic acid examined in one patient was lowered. Evidence obtained indicated that the Reye-like syndrome might be caused by calcium hopantenate possibly due to the induction of pantothenic acid deficiency.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Biopsy
  • Dementia / drug therapy*
  • Female
  • Humans
  • Liver / drug effects
  • Liver / pathology
  • Microscopy, Electron
  • Pantothenic Acid / adverse effects
  • Pantothenic Acid / analogs & derivatives*
  • Pantothenic Acid / antagonists & inhibitors*
  • Pantothenic Acid / therapeutic use
  • Reye Syndrome / chemically induced*
  • Reye Syndrome / pathology
  • gamma-Aminobutyric Acid / adverse effects
  • gamma-Aminobutyric Acid / analogs & derivatives*
  • gamma-Aminobutyric Acid / therapeutic use

Substances

  • pantogab
  • Pantothenic Acid
  • gamma-Aminobutyric Acid